0000000000971759

AUTHOR

G. D’amico

showing 4 related works from this author

The Clinical Course of Portal Hypertension in Liver Cirrhosis

2000

Portal hypertension is caused by liver cirrhosis in almost %% of patients in Europe and in North America. Other causes such as hepato-splenic schistosomiasis, noncirrhotic portal fibrosis and extrahepatic portal vein thrombosis are more common in Asia and South America.

medicine.medical_specialtyCirrhosisbusiness.industryPortal venous pressurePortal hypertensive gastropathySchistosomiasismedicine.diseaseGastroenterologyPortal vein thrombosisEsophageal varicesInternal medicinePortal fibrosismedicinePortal hypertensionbusiness
researchProduct

Prevention of Upper Gastrointestinal Bleeding in Cirrhotic Patients

1987

The prevalence of varices in patients with cirrhosis is stated to be about 50% and the risk of variceal bleeding 40% with mortality ranging from 30% to 60%. Differences may be due to patient selection and diagnostic criteria. The death risk of first bleeding seems to be higher than that of subsequent episodes (Christensen et al. 1981; D’Amico et al. 1986), indicating that the first bleeding episode causes a selection.

Gastrointestinal bleedingmedicine.medical_specialtyVariceal bleedingCirrhosisbusiness.industrymedicine.diseaseGastroenterologyEsophageal varicesInternal medicinemedicinePortal hypertensionIn patientUpper gastrointestinal bleedingbusinessVarices
researchProduct

Sensitivity of the Cherenkov Telescope Array to a dark matter signal from the Galactic centre

2021

Full list of authors: Acharyya, A.; Adam, R.; Adams, C.; Agudo, I.; Aguirre-Santaella, A.; Alfaro, R.; Alfaro, J.; Alispach, C.; Aloisio, R.; Alves Batista, R.; Amati, L.; Ambrosi, G.; Angüner, E. O.; Antonelli, L. A.; Aramo, C.; Araudo, A.; Armstrong, T.; Arqueros, F.; Asano, K.; Ascasíbar, Y. Ashley, M.; Balazs, C.; Ballester, O.; Baquero Larriva, A.; Barbosa Martins, V.; Barkov, M.; Barres de Almeida, U.; Barrio, J. A.; Bastieri, D.; Becerra, J.; Beck, G.; Becker Tjus, J.; Benbow, W.; Benito, M.; Berge, D.; Bernardini, E.; Bernlöhr, K.; Berti, A.; Bertucci, B.; Beshley, V.; Biasuzzi, B.; Biland, A.; Bissaldi, E.; Biteau, J.; Blanch, O.; Blazek, J.; Bocchino, F.; Boisson, C.; Bonneau Arbe…

Cherenkov Telescope ArrayMATÉRIA ESCURAscale: TeVAstronomyatmosphere [Cherenkov counter]dark matter experimentDark matter theoryenergy resolutionGamma ray experimentsParticleAstrophysicscosmic background radiation01 natural sciences7. Clean energyHigh Energy Physics - Phenomenology (hep-ph)benchmarkWIMPHESSenergy: fluxTeV [scale]relativistic [charged particle]gamma ray experimentMAGIC (telescope)Monte CarloEvent reconstructionPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Contractionspatial distributiontrack data analysisPhysicsdensity [dark matter]ClumpyAstrophysics::Instrumentation and Methods for AstrophysicsimagingHigh Energy Physics - Phenomenologydark matter experiments; dark matter theory; gamma ray experiments; galaxy morphologyDark matter experimentsFísica nuclearVERITASAstrophysics - High Energy Astrophysical PhenomenaSimulationsnoiseWIMPAstrophysics::High Energy Astrophysical PhenomenaDark mattersatelliteCosmic background radiationFOS: Physical sciencesAnnihilationdark matter: densityAstrophysics::Cosmology and Extragalactic AstrophysicsCherenkov counter: atmosphereheavy [dark matter]530annihilation [dark matter]GLASTDark matter experiments; Dark matter theory; Galaxy morphology; Gamma ray experimentscosmic radiation [p]0103 physical sciencesCherenkov [radiation]Candidatesddc:530AGNCherenkov radiationRadiative Processesthermal [cross section]010308 nuclear & particles physicsFísicadark matter: annihilationGamma-Ray SignalsCherenkov Telescope Array ; dark matter ; Galactic Center ; TeV gamma-ray astronomyAstronomy and AstrophysicsMassCherenkov Telescope Arrayradiation: CherenkovsensitivityMAGICGalaxyAstronomíadark matter: heavygamma rayp: cosmic radiation[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]correlationcharged particle: relativisticflux [energy]Galaxy morphology/dk/atira/pure/subjectarea/asjc/3100/3103galaxysupersymmetry[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]cross section: thermal
researchProduct

Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

2018

OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk factor for bleeding events. However, the relationship between platelet count and bleeding is still unclear. METHODS: We investigated the relationship between platelet count and major or clinical relevant nonmajor bleedings during a follow-up of ∼4 years. RESULTS: A total of 280 cirrhotic patients with different degrees of liver disease (67% males; age 64±37 years; 47% Child–Pugh B and C) were followed up for a median of 1,129 (interquartile range: 800–1,498) days yielding 953.12 patient-year of observation. The annual rate of any significant bleeding was 5.45%/year (3.57%/year and 1.8…

Liver CirrhosisMaleSettore MED/09 - Medicina Interna030204 cardiovascular system & hematologyGastroenterologySeverity of Illness IndexcjirrhosisACTIVATION0302 clinical medicineRisk FactorsMedicinePlateletProspective StudiesProspective cohort studyRISKAged 80 and overmedicine.diagnostic_testPRO-LIVERPlatelet cirrhosis gastrointestinal bleedingPlateletGastroenterologyASSOCIATIONMiddle AgedPrognosisItaly030211 gastroenterology & hepatologyFemaleGastrointestinal HemorrhageHumanAdultPlateletsmedicine.medical_specialtyPrognosiLiver CirrhosiMEDLINECOAGULATIONgastrointestinal bleedingSocio-culturaleHemorrhageHepatology; GastroenterologyFollow-Up Studie03 medical and health sciencesText miningInternal medicineSeverity of illnessENDOTOXEMIAPro-Liver StudyHumansHEMOSTASISInternational Normalized RatioAgedProportional Hazards ModelsProthrombin timeCirrhosiHepatologyPlatelet Count Bleeding Liver Cirrhosisbusiness.industryProportional hazards modelPlatelet CountRisk FactorcirrhosisHepatologybleedingThrombocytopeniaProspective StudieTHROMBOSISPlatelets cjirrhosis bleeding PRO-LIVERProportional Hazards ModelProthrombin TimebusinessDECOMPENSATED CIRRHOSISFollow-Up Studies
researchProduct